Radnet Management to offer $210M senior notes due 2018

NewsGuard 100/100 Score

RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 180 imaging centers, today announced that its wholly-owned subsidiary Radnet Management, Inc. (the "Issuer") intends to offer $210 million in aggregate principal amount of senior notes due 2018 (the "Notes") to qualified institutional buyers in a private placement that will be exempt from the registration requirements of the Securities Act of 1933, as amended and subject to market and other conditions.

The Notes will be issued by the Issuer and guaranteed jointly and severally on a senior basis by the Company and all of the Issuer's current and future wholly-owned domestic restricted subsidiaries.

The Company intends to use the net proceeds from the private placement, together with borrowings under its previously announced new senior secured credit facilities to refinance existing credit facilities, fund its previously announced acquisitions currently under letters of intent and pay related fees and expenses. Entry into the senior secured credit facilities and the proposed offering of the Notes will be conditioned on each transaction being consummated, and there is no assurance that the proposed financing transactions will be effectuated on the terms presented, or at all.

Source:

RadNet, Inc.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can synthetic data boost fairness in medical imaging AI?